MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease
- 4 May 2022
- journal article
- research article
- Published by Elsevier in Progress in Neurobiology
- Vol. 214, 102280
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31970733, 32070988)
- China Postdoctoral Science Foundation (2019M651012, 2020T130324)
- Higher Education Discipline Innovation Project (B08011)
This publication has 56 references indexed in Scilit:
- FoxO3a is activated and executes neuron death via Bim in response to β-amyloidCell Death & Disease, 2013
- Switching off LTP: mGlu and NMDA Receptor-Dependent Novelty Exploration-Induced Depotentiation in the Rat HippocampusCerebral Cortex, 2012
- p53 Pro-Oxidant Activity in the Central Nervous System: Implication in Aging and Neurodegenerative DiseasesAntioxidants & Redox Signaling, 2011
- Caspases firstNature Reviews Neurology, 2010
- Caspase activation precedes and leads to tanglesNature, 2010
- Alzheimer's disease: a global challenge for the 21st centuryThe Lancet Neurology, 2009
- Modes of p53 RegulationCell, 2009
- Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse modelNeurobiology of Disease, 2009
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006
- Long-Term Potentiation and MemoryPhysiological Reviews, 2004